The true specific cause of pancreatic cancer (ductal adenocarcinoma of the pancreas) in an individual is generally never fully known. But there are population level studies which demonstrate associations between specific behaviors or characteristics and pancreatic cancer. And pancreatic cancer is more common in some families, for example those who appear to carry one of the BRCA genetic mutations which are found more commonly in Ashkenazi Jewish backgrounds and certainly others.

A risk factor is a variable that may tend to increase an individual’s risk of acquiring pancreatic cancer. Who we are and what we do has some effect on the diseases that we may contract. In this process, pancreatic cancer is no different from other diseases; although there is still a great deal that we do not understand about the cause and effect of risk factors to pancreatic cancer.

Having many risk factors does not necessarily mean that one will contract pancreatic cancer. And again in many individuals, there is no fully understood reason why they may have acquired the disease. It is important to understand the limitation of this central idea of risk factors – they are perhaps useful but not definitive.

The incidence of pancreatic cancer increases with age; most people are between the ages of 60 to 80 when they receive the diagnosis. The median age at the diagnosis of pancreatic cancer is between 70 and 71 years old. Men had tended to be over-represented, though in recent years the gap between men and women has shrunk, possibly due to increased cigarette smoking among women. It was observed in the past that men had about an up to 30% increased risk of acquiring pancreatic cancer (over women), but for unexplained reasons, possibly smoking, this gender gap seems in more recent times to have significantly decreased.

African Americans tend to be more likely to acquire cancer of the pancreas as compared to their Caucasian counterparts. The causes of this are not entirely clear, but may have to do with diet, smoking, diabetes rates, and obesity.

Cigarette smoking is a prominent risk factor. Between 20-30% of cases of pancreatic cancer are thought to be attributable to smoking. Other forms of tobacco use (including smokeless forms) can increase risk too. But it is also true that at about ten years after quitting smoking, the rate of pancreatic cancer moves about back to that of those who have never smoked.

Pancreatic cancer is more likely in those with diabetes, but the study results are a bit mixed. It is not entirely clear if diabetes is a cause or a result. This includes and may be especially true in those with type 2 diabetes. Similarly, those who are obese have an increased risk of acquiring pancreatic cancer, though some of this may be explained on the basis of the relationship between diabetes and obesity.

Certain published medical articles have associated diets rich in fat, with a high level of meat, and/or with processed meat to be linked to a higher rate of pancreatic cancer. Coffee is currently thought not to be a risk factor for pancreatic cancer. Moderate intake of alcohol appears relatively safe, but in recent studies the excessive and prolonged drinking of alcohol has been linked to an increased likelihood of pancreatic cancer.


Certain illnesses which may or may not appear to directly affect the pancreas appear to confer an increased possibility of contracting pancreatic cancer – and thus are risk factors. These include, for example, chronic pancreatitis, cirrhosis of the liver, peptic ulcer disease associated with the Helicobacter pylori (H. pylori) bacteria, and certain kinds of hepatitis.

Prolonged exposures to given metals, chemical and dyes may be risk factors for pancreatic cancer.

Pancreatic cancer can run in some families due to increased risk factors related to genetics. It is thought that having a genetic predisposition may be responsible for as much as 10% of pancreatic cancer.

Some of the genetic type syndromes or disease complexes that can dispose to a higher incidence of pancreatic cancer (adenocarcinoma) include familial mutations in the BRCA1 and BRCA2 genes, genetic melanoma, genetic chronic pancreatitis, genetic non-polyp colorectal tumor (Lynch syndrome), Peutz-Jeghers syndrome, and Von Hippel-Lindau syndrome.

Neuroendocrine tumors, islet cell tumors and carcinoid tumors can also, for example, be associated with hereditary predisposition tendency diseases such as neurofibromatosis, and with various “multiple endocrine neoplasia” (MEN) type syndromes.


The following are descriptions of titles of abstracts of medical journal articles that may be interesting or useful to those who are interested in further information about this topic.These abstracts can be searched Here.

  • 1-Nov-16 – External risk factors for cancer of the pancreas 
  • 14-Oct-16 – Microbiota of the mouth associated with risk of cancer of the pancreas 
  • 1-Nov-15 – Cancer of the pancreas: Industrial and environmental exposures 
  • 1-Dec-13 – Periodontal Disease and Adenocarcinoma of the Pancreas
  • 1-Dec-13 – White Cell Telomeres and the Risk for Cancer of the Pancreas
  • 20-Nov-13 – Higher Dosage of Apririn Protective Against Cancer of the Pancreas
    • 21-Aug-13 – Familial Diabetes Mellitus and Cancer of the Pancreas
    • 14-Jul-13 – Liver Viruses Associated with Adenocarcinoma of the Pancreas?
    • 1-Apr-13 – Increased Risk of Pancreatic Cancer for Type A Blood Group
    • 1-Jan-13 – Diabetes Mellitus as a Risk Factor for Pancreatic Cancer
    • 15-May-12 – Diabetes Drug Improves Survival in Cancer of the Pancreas
    • 1-Sep-11 – Pancreatic Cancer Patients with BRCA Gene – Treat with DNA Cross-linking Drug Agents
  • 1-Aug-11 – Full Response of Patient with BRCA Gene and Pancreatic Cancer to Platinum Drug Therapy
  • 1-May-11 – Screening Family Members at High Risk for Cancer of the Pancreas
  • 1-Apr-11 – Targeted Therapy for BRCA Pancreatic Cancer
  • 1-Nov-09 – Increased Risk in Family Members with a History of Cancer of the Pancreas
  • 1-Oct-09 – Possible Link of HBV to Pancreatic Cancer
  • 8-May-08 – MMC Chemo for a patient with BRCA Gene
  • 1-Apr-04 – Familial Risk for Cancer of the Pancreas
  • 15-Jun-03 – Diet as a Risk Factor for Pancreatic cancer
  • 5-Feb-03 – Pancreatic Cancer in Families with BRACA2 Gene Mutations


Our science board is composed of:

James Abbruzzese, MD Chief, Medical Oncology Duke University

Markus Büchler, MD Chairman, Surgery Heidelberg University, Germany

Ralph Hruban, MD Director, GI / Liver Pathology Johns Hopkins University

Eileen O’Reilly, MD Associate Director for Clinical Research – Memorial Sloan-Kettering Cancer Center

Margaret Tempero, MD Chief, Medical Oncology University of California at San Francisco

Our Philosophy About Pancreatic Cancer

Pancreatic cancer is a serious disease. Taking an aggressive rational stance at the earliest possible time, supported by the best medical team, and treated in the most appropriate manner gives the best chance for survival.

We believe in strong patient-physician bonds, scientifically-based treatment, and that comfort can come from knowing that everything that reasonably can be done – is being done.

That the best approach is meeting cancer of the pancreas head-on and armed with the best available information.

Facebook Fundraising is Easy!

Creating a Facebook Fundraiser is easy: Click the Link below and Facebook will take you through the steps! Dedicate your Birthday or another important date to honor a loved one.


To Safely make a Donation via Text, Text the Code FIGHTPC to number 44-321

Making IMPACT for Pancreatic Cancer Together!

Join our expanding community on Facebook! Connect with others, share stories, and get support! Click Here


Regular giving can be an opportunity to pay tribute in honour of a loved one. Your monthly gift will go directly to promoting awareness, increasing education, furthering pancreatic cancer research aimed at early diagnosis and, helping patients and families impacted by the effects of pancreatic cancer.

Simply select “Monthly” after choosing the amount you would like to give.

Genetic Testing for Pancreatic Cancer

PROPOSED: Every newly diagnosed person with pancreatic cancer (ductal adenocarcinoma of the pancreas) should receive genetic screening prior to beginning treatment – to test for germline genetic mutations in the homologous recombination DNA repair pathway, including genes such as BRCA1, BRCA2, PALB2, and others. These results, in from 12% to 17% of pancreatic cancer patients, suggest that treatment that includes DNA cross-linking agents such as platinum compounds or PARP inhibitors may be superior to standard best practices therapy.

OFFER: Color Genomics offers a 30-gene cancer panel for $224 (normally $249) when the Promotion Code “PANCREATIC” is entered at checkout (price will reduce upon entering this code). This is a physician-ordered saliva kit. Click Here for more information

RATIONALE: The age of precision medicine in pancreatic cancer is approaching … [MORE]

This year an estimated 57,600 Americans will be diagnosed with pancreatic cancer. Approximately 47,050 Americans are expected to die from the disease. There are many reasons why the outcome for pancreatic cancer patients is bleaker than for most other cancer types. There are no reliable methods to detect the disease early, and there are very few effective treatment options. Which is why we are so focused on supporting research for early diagnosis.

Together with You our Mission is to promote awareness, increase education, and further pancreatic cancer research aimed at early diagnosis.

Most of our fundraisers, supporters, and volunteers, have been in one way or another, personally effected by this disease. We want to acknowledge what hardships you may have gone through (or are currently facing) and sincerely thank you for visiting our site!

Walk, Run, or Choose your own!

Choose a walk, run, or any other activity that you like and work to raise donations leading up to your Event! Simply set up your participation page and we will be in touch!


Already registered for your next Race? Dedicate your participation to Pancreatic Cancer. Simply set up your participation page and together we will work towards our shared mission!


Creating a Facebook Fundraiser is easy: Click the Link below and Facebook will take you through the steps! Dedicate your Birthday or another important date to honor a loved one.


Create your own fun, choose something you already love to support pancreatic cancer! Simply set up your participation page, include the details of your fundraiser on your page, and get the word out!

Cancer Patients Alliance is a 501(c)(3) non-profit. Initiatives include, and All Donations are tax-deductible.

Pancreatic cancer is expected to become the 2nd leading cause of cancer-related death by the year 2020. There are many reasons why the outcome for pancreatic cancer patients is much bleaker than for most other cancer types. There are no reliable methods to detect the disease early, and there are very few effective treatment options.

There remains a dire need for more research and an increase in focused funding for pancreatic cancer. Your Donation will go directly to promoting awareness, increasing education, and furthering pancreatic cancer research aimed at early diagnosis.

Amazon donates 0.5% of the price of your eligible AmazonSmile purchases to help fight pancreatic cancer!
AmazonSmile is the same Amazon you know. Same products, same prices, same service. Simply use our Link to start shopping!

Best of the Blog

Speak with a Survivor:

Call 1-800-433-0464 for a free service that will place you in contact with a fellow survivor, or to volunteer to contact someone more recently diagnosed.

Pancreatic Cancer Blog

One of the observations that physicians often made when the standard of care treatment typically consisted of the chemotherapy drug agent of gemcitabine alone, was that many patients with pancreatic cancer (ductal adenocarcinoma of the pancreas) seemed to feel better after the initiation of treatment… More Here


Join us on Social Media !

Pay tribute to your Loved one.

Honor a Loved One with a Monthly Gift!